151 related articles for article (PubMed ID: 22348389)
1. ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas.
Yamamoto S; Tsuda H; Honda K; Takano M; Tamai S; Imoto I; Inazawa J; Yamada T; Matsubara O
Histopathology; 2012 Jun; 60(7):1073-83. PubMed ID: 22348389
[TBL] [Abstract][Full Text] [Related]
2. Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas.
Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
Mod Pathol; 2012 Jan; 25(1):122-30. PubMed ID: 21983935
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma.
Kato M; Yamamoto S; Takano M; Matsubara O; Furuya K
Int J Gynecol Pathol; 2012 May; 31(3):254-63. PubMed ID: 22498943
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.
Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
Virchows Arch; 2009 Nov; 455(5):413-22. PubMed ID: 19855998
[TBL] [Abstract][Full Text] [Related]
5. Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance.
Yamamoto S; Tsuda H; Honda K; Onozato K; Takano M; Tamai S; Imoto I; Inazawa J; Yamada T; Matsubara O
Mod Pathol; 2009 Apr; 22(4):499-507. PubMed ID: 19151661
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
Yamamoto S; Tsuda H; Takano M; Iwaya K; Tamai S; Matsubara O
J Pathol; 2011 Oct; 225(2):189-94. PubMed ID: 21735444
[TBL] [Abstract][Full Text] [Related]
7. Cumulative alterations of p27-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
Histopathology; 2010 May; 56(6):740-9. PubMed ID: 20546339
[TBL] [Abstract][Full Text] [Related]
8. Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient.
Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O
Mod Pathol; 2011 Aug; 24(8):1146-55. PubMed ID: 21478826
[TBL] [Abstract][Full Text] [Related]
9. Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas.
Kikuchi S; Honda K; Tsuda H; Hiraoka N; Imoto I; Kosuge T; Umaki T; Onozato K; Shitashige M; Yamaguchi U; Ono M; Tsuchida A; Aoki T; Inazawa J; Hirohashi S; Yamada T
Clin Cancer Res; 2008 Sep; 14(17):5348-56. PubMed ID: 18765526
[TBL] [Abstract][Full Text] [Related]
10. Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors.
Yamamoto S; Tsuda H; Takano M; Kita T; Kudoh K; Furuya K; Tamai S; Matsubara O
Mod Pathol; 2008 Feb; 21(2):115-24. PubMed ID: 18084257
[TBL] [Abstract][Full Text] [Related]
11. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway.
Yamamoto S; Tsuda H; Takano M; Hase K; Tamai S; Matsubara O
J Pathol; 2008 Sep; 216(1):103-10. PubMed ID: 18600856
[TBL] [Abstract][Full Text] [Related]
12. Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics.
Yamamoto S; Tsuda H; Yoshikawa T; Kudoh K; Kita T; Furuya K; Tamai S; Matsubara O
Am J Surg Pathol; 2007 Jul; 31(7):999-1006. PubMed ID: 17592265
[TBL] [Abstract][Full Text] [Related]
13. [Significance and mechanisms of overexpression of PAK1 gene in epithelial ovarian neoplasms].
Xie D; Yang GF; Chen YQ; Jiang LF; Xiao LZ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):911-4. PubMed ID: 17533742
[TBL] [Abstract][Full Text] [Related]
14. HER-2/neu gene amplification in ovarian tumours: a comprehensive immunohistochemical and FISH analysis on tissue microarrays.
Mayr D; Kanitz V; Amann G; Engel J; Burges A; Löhrs U; Diebold J
Histopathology; 2006 Jan; 48(2):149-56. PubMed ID: 16405663
[TBL] [Abstract][Full Text] [Related]
15. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.
Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
Mod Pathol; 2012 Apr; 25(4):615-24. PubMed ID: 22157930
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer.
Kakuya T; Mori T; Yoshimoto S; Watabe Y; Miura N; Shoji H; Onidani K; Shibahara T; Honda K
Int J Oral Maxillofac Surg; 2017 Aug; 46(8):968-976. PubMed ID: 28385383
[TBL] [Abstract][Full Text] [Related]
17. Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.
Noro R; Honda K; Tsuta K; Ishii G; Maeshima AM; Miura N; Furuta K; Shibata T; Tsuda H; Ochiai A; Sakuma T; Nishijima N; Gemma A; Asamura H; Nagai K; Yamada T
Ann Oncol; 2013 Oct; 24(10):2594-2600. PubMed ID: 23899839
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma.
Rahman MT; Nakayama K; Rahman M; Nakayama N; Ishikawa M; Katagiri A; Iida K; Nakayama S; Otsuki Y; Shih IeM; Miyazaki K
Cancer; 2012 Jun; 118(11):2846-57. PubMed ID: 22139760
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological heterogeneity in ovarian clear cell adenocarcinoma: a study on individual therapy practice.
Matsuo Y; Tashiro H; Yanai H; Moriya T; Katabuchi H
Med Mol Morphol; 2015 Sep; 48(3):146-54. PubMed ID: 25398420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
